Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Melanoma 6Lymphoma, B-Cell 5Uveal Melanoma 4Esophageal Neoplasms 4Colorectal Neoplasms 4Recurrence 3Polycystic Ovary Syndrome 3Neoplasms, Plasma Cell 3Multiple Myeloma 3Hematologic Neoplasms 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Follicular 2Lymphoma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Head and Neck Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Burkitt Lymphoma 2Breast Neoplasms 2Urinary Bladder Neoplasms 1

Interventions

Pemetrexed 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × OTHER_GOV × Non-squamous Cell Non-Small Cell Lung Cancer × Clear all
NCT03790228 2020-04-15

Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC

Henan Cancer Hospital

Phase 1 Unknown
43 enrolled
Thoracic

Non-squamous Cell Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡